COMIRNATY®
(COVID-19 Vaccine, mRNA)
is a vaccine indicated for active immunization to prevent coronavirus disease 2019
(COVID-19)
caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)
in individuals 12 years of age and older. It is also authorized for emergency use to provide a third primary series dose to individuals 12 years of age and older with certain kinds of immunocompromise.
AUTHORIZED USE
Pfizer-BioNTech
COVID-19
Vaccine
and
Pfizer-BioNTech
COVID-19
Vaccine, Bivalent (Original and Omicron BA.4/BA.5)
are FDA authorized under Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019
(COVID-19)
caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)
in individuals 6 months of age and older.
Interchangeability of COMIRNATY and Pfizer-BioNTech COVID-19 Vaccine (Primary Series for Individuals 12 Years of Age and Older)
When prepared according to their respective instructions for use, the FDA-approved COMIRNATY and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older can be used interchangeably without presenting any safety or effectiveness concerns.